Prenetics Global Limited (PRE) — Stock Score Summary

Prenetics Global Limited (PRE) has a MoatMap StockRank of 74/100 based on Quality (40/100), Value (44/100), and Momentum (73/100) factor scores. The current signal is BUY. Prenetics is a diagnostics and genomics company that lacks alignment with our high-conviction macro themes. The business model does not exhibit the high ROIC or structural pricing power required by our Terry Smith lens, and the quality score is weak.

Prenetics Global Limited is a global leader in genomics and diagnostics, offering a range of genetic testing and health screening solutions, including preventative health and infectious disease testing. The company's competitive advantage stems from its advanced laboratory capabilities, proprietary technology, and broad geographical reach, particularly in Asia. It plays a significant role in making personalized and preventative health accessible.

Key Financial Metrics

Price$20.83
Market Cap$343M
P/E (Forward)-26.19
Price/Book1.64
Return on Equity-22.1%
Return on Invested Capital-20.3%
Debt/Equity1.13
Gross Margin52.8%
Operating Margin-37.2%
Free Cash Flow$-73M

Prenetics Global Limited operates in the Diagnostics & Research industry, part of the Healthcare sector (Hong Kong).

Frequently Asked Questions

What is Prenetics Global Limited’s (PRE) StockRank?
MoatMap’s StockRank for Prenetics Global Limited (PRE) is 74/100, with a Buy signal. It is a composite of Quality (40), Value (44), and Momentum (73) factor ranks across MoatMap’s 19,000+ stock universe.
Does Prenetics Global Limited have an economic moat?
Prenetics Global Limited (PRE) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Prenetics Global Limited a buy, hold, or sell?
MoatMap’s current signal for Prenetics Global Limited (PRE) is Buy, based on a StockRank of 74/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Prenetics Global Limited in?
Prenetics Global Limited (PRE) operates in the Healthcare sector, specifically the Diagnostics & Research industry (Hong Kong).
Browse all ranked stocksPRE deep dive reportAI ChampionsHow we score stocksSense-check another stock